References
- WHO. Coronavirus (COVID-19) dashboard; 2023 [cited 2023 Oct 16]. Available from: https://covid19.who.int/
- WHO. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. Geneva; 2014 [cited 2023 Nov 1]. Available from: https://iris.who.int/handle/10665/112656
- WHO. Transmission-based precautions for the prevention and control of infections: aide-memoire; 2022 [cited 2023 Nov 1]. Available from: https://www.who.int/publications/i/item/WHO-UHL-IHS-IPC-2022.2
- Li Y. Basic routes of transmission of respiratory pathogens – a new proposal for transmission categorization based on respiratory spray, inhalation, and touch. Indoor Air. 2021;31(1):3–6. doi: 10.1111/ina.12786.
- Li Y. The respiratory infection inhalation route continuum. Indoor Air. 2021;31(2):279–281. doi: 10.1111/ina.12806.
- WHO. Coronavirus disease (COVID-19): how is it transmitted? 2023 [cited 2023 Nov 1]. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-how-is-it-transmitted
- CDC. How coronavirus spreads; 2023 [cited 2023 Nov 1]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html
- Public Health Agency of Canada. COVID-19: prevention and risks; 2023 [cited 2023 Nov 1]. Available from: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks.html#h
- Public Health Agency of Sweden. FAQ about COVID-19; 2023 [cited 2023 Nov 1]. Available from: https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/covid-19/covid-19-faq/
- Lin YC, Malott RJ, Ward L, et al. Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples. Sci Rep. 2022;12(1):5418. doi: 10.1038/s41598-022-09218-5.
- Stern RA, Charness ME, Gupta K, et al. Concordance of SARS-CoV-2 RNA in aerosols from a nurses station and in nurses and patients during a hospital ward outbreak. JAMA Netw Open. 2022;5(6):e2216176. doi: 10.1001/jamanetworkopen.2022.16176.
- Otter JA, Zhou J, Price JR, et al. SARS-CoV-2 surface and air contamination in an acute healthcare setting during the first and second pandemic waves. J Hosp Infect. 2023;132:36–45. doi: 10.1016/j.jhin.2022.11.005.
- Rufino de Sousa N, Steponaviciute L, Margerie L, et al. Detection and isolation of airborne SARS‐CoV‐2 in a hospital setting. Indoor Air. 2022;32(3):e13023. doi: 10.1111/ina.13023.
- Nannu Shankar S, Witanachchi CT, Morea AF, et al. SARS-CoV-2 in residential rooms of two self-isolating persons with COVID-19. J Aerosol Sci. 2022;159:105870. doi: 10.1016/j.jaerosci.2021.105870.
- Lednicky JA, Lauzard M, Fan ZH, et al. Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int J Infect Dis. 2020;100:476–482. doi: 10.1016/j.ijid.2020.09.025.
- Santarpia JL, Rivera DN, Herrera VL, et al. Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Sci Rep. 2020;10(1):12732. doi: 10.1038/s41598-020-69286-3.
- Chia PY, Coleman KK, Tan YK, et al. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat Commun. 2020;11(1):2800. doi: 10.1038/s41467-020-16670-2.
- Adenaiye OO, Lai J, Bueno de Mesquita PJ, et al. Infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in exhaled aerosols and efficacy of masks during early mild infection. Clin Infect Dis. 2022;75(1):e241–e248. doi: 10.1093/cid/ciab797.
- Alsved M, Nyström K, Thuresson S, et al. Infectivity of exhaled SARS-CoV-2 aerosols is sufficient to transmit covid-19 within minutes. Sci Rep. 2023;13(1):21245. doi: 10.1038/s41598-023-47829-8.
- Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26(5):676–680. doi: 10.1038/s41591-020-0843-2.
- Lindsley WG, Blachere FM, Beezhold DH, et al. Viable influenza A virus in airborne particles expelled during coughs versus exhalations. Influenza Other Respir Virus. 2016;10(5):404–413. doi: 10.1111/irv.12390.
- Lindsley WG, Blachere FM, Thewlis RE, et al. Measurements of airborne influenza virus in aerosol particles from human coughs. PLOS One. 2010;5(11):e15100. doi: 10.1371/journal.pone.0015100.
- Lindsley WG, Noti JD, Blachere FM, et al. Viable influenza A virus in airborne particles from human coughs. J Occup Environ Hyg. 2015;12(2):107–113. doi: 10.1080/15459624.2014.973113.
- Milton DK, Fabian MP, Cowling BJ, et al. Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog. 2013;9(3):e1003205. doi: 10.1371/journal.ppat.1003205.
- Rufino de Sousa N, Sandström N, Shen L, et al. A fieldable electrostatic air sampler enabling tuberculosis detection in bioaerosols. Tuberculosis. 2020;120:101896. doi: 10.1016/j.tube.2019.101896.
- Smyrlaki I, Ekman M, Lentini A, et al. Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR. Nat Commun. 2020;11(1):4812. doi: 10.1038/s41467-020-18611-5.
- Rufino de Sousa N, Steponaviciute L, Margerie L, et al. Plaque-forming units from air samples: Letter to Editor. Re: Jefferson et al., Indoor Air, 2022. Indoor Air. 2022;32(11):e13169. doi: 10.1111/ina.13169.
- Lentini A, Papanicolaou N, Reinius B. Whole genome sequencing of in vitro propagated SARS-CoV-2 at the Karolinska Institutet BSL-3 Core Facility. Zenodo; 2021. 10.5281/zenodo.4722501
- Johnson TJ, Nishida RT, Sonpar AP, et al. Viral load of SARS-CoV-2 in droplets and bioaerosols directly captured during breathing, speaking and coughing. Sci Rep. 2022;12(1):3484. doi: 10.1038/s41598-022-07301-5.
- Coleman KK, Tay DJW, Tan KS, et al. Viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory aerosols emitted by patients with coronavirus disease 2019 (COVID-19) while breathing, talking, and singing. Clin Infect Dis. 2022;74(10):1722–1728. doi: 10.1093/cid/ciab691.
- Alsved M, Nygren D, Thuresson S, et al. Size distribution of exhaled aerosol particles containing SARS-CoV-2 RNA. Infect Dis. 2023;55(2):158–163. doi: 10.1080/23744235.2022.2140822.
- Oswin HP, Haddrell AE, Otero-Fernandez M, et al. The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment. Proc Natl Acad Sci U S A. 2022;119(27):e2200109119. doi: 10.1073/pnas.2200109119.
- Smither SJ, Eastaugh LS, Findlay JS, et al. Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity. Emerg Microbes Infect. 2020;9(1):1415–1417. doi: 10.1080/22221751.2020.1777906.
- Killingley B, Mann AJ, Kalinova M, et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat Med. 2022;28(5):1031–1041. doi: 10.1038/s41591-022-01780-9.
- Goldswain H, Dong X, Penrice-Randal R, et al. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection. Genome Biol. 2023;24(1):47. doi: 10.1186/s13059-023-02881-5.
- Liu Y, Liu J, Johnson BA, et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. Cell Rep. 2022;39(7):110829. doi: 10.1016/j.celrep.2022.110829.
- Khandelwal N, Chander Y, Kumar R, et al. Studies on growth characteristics and cross-neutralization of wild-type and delta SARS-CoV-2 from Hisar (India). Front Cell Infect Microbiol. 2021;11:771524. doi: 10.3389/fcimb.2021.771524.
- Yan J, Grantham M, Pantelic J, et al. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proc Natl Acad Sci U S A. 2018;115(5):1081–1086. doi: 10.1073/pnas.1716561115.